Predictors of the Patient Interval. Table with results of the Cox Regression analysis (DOCX 17Â kb
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb
Supplementary Figures and Tables. This file contains the following figures and tables: Validation of...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Predictors of the Diagnostic Interval. Table with results of the Cox Regression analysis (DOCX 15Â k...
Predictors of the Pre-Treatment Interval. Table with results of the Cox Regression analysis (DOCX 14...
Table S1. Univariate and multivariate Cox regression analyses of TILs, LMR, and clinicopathological ...
Table S4. Unadjusted Cox regression analyses of patient and tumor characteristics at baseline. (PDF ...
Table S1. HR+ and HER2- advanced breast cancer disease-related and treatment-related concept frequen...
Table S2. Effects of BRCA germline mutation and other prognostic factors (all covariates) on clinica...
Table S3. HR+ and HER2- advanced breast cancer health and well-being impact concept descriptions. (D...
Patient characteristics of the 6,248 patients shown by trial. Table S2. National Cancer Institute Co...
Table S1. Relative Risk (RR) and 95% confidence interval (95% CI) of risk factors associated with br...
Tumor, lymph node, metastasis (TNM) classification for defining subgroups of patients with locally a...
Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a low risk according to...
Table S1. Multivariate-adjusteda hazard ratios (HRs) and 95% confidence intervals for breast cancer ...
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb
Supplementary Figures and Tables. This file contains the following figures and tables: Validation of...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Predictors of the Diagnostic Interval. Table with results of the Cox Regression analysis (DOCX 15Â k...
Predictors of the Pre-Treatment Interval. Table with results of the Cox Regression analysis (DOCX 14...
Table S1. Univariate and multivariate Cox regression analyses of TILs, LMR, and clinicopathological ...
Table S4. Unadjusted Cox regression analyses of patient and tumor characteristics at baseline. (PDF ...
Table S1. HR+ and HER2- advanced breast cancer disease-related and treatment-related concept frequen...
Table S2. Effects of BRCA germline mutation and other prognostic factors (all covariates) on clinica...
Table S3. HR+ and HER2- advanced breast cancer health and well-being impact concept descriptions. (D...
Patient characteristics of the 6,248 patients shown by trial. Table S2. National Cancer Institute Co...
Table S1. Relative Risk (RR) and 95% confidence interval (95% CI) of risk factors associated with br...
Tumor, lymph node, metastasis (TNM) classification for defining subgroups of patients with locally a...
Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a low risk according to...
Table S1. Multivariate-adjusteda hazard ratios (HRs) and 95% confidence intervals for breast cancer ...
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb
Supplementary Figures and Tables. This file contains the following figures and tables: Validation of...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
DOI
Add to ORKG